Stock Screener App

無料 -

インストール

10.01

0.05% 0.005

after-market

アフターアワーズ： 10.01

Drugs Made In America Acquisition Ii Corp (DMII)

概要ニュース株価時系列ディスカッション予測

Drugs Made In America Acquisition Ii Corp (DMII) 最新ニュース

Drugs Made in America (NASDAQ: DMAA) details new CEO pay deal - Stock Titan

DRUMMOND VEN: Performance & Quotes, MACK Stock Price on Toronto S.E. Exchange - marketscreener.com

ETFs Investing in Drugs Made In America Acquisition II Corp. Stocks - TradingView

Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5% - MarketBeat

DMAA | Drugs Made In America Insider Trading - Quiver Quantitative

Illumination Acquisition Corp I: Performance & Quotes, ILLU Stock Price on Nasdaq Exchange - marketscreener.com

AlphaTON Capital Corp. (ALP) - Minichart

DMII Price History for Drugs Made IN America Acquisition II Stock - Barchart.com

DMAAR Price History for Drugs Made IN America Acquisition Corp. Rights Stock - Barchart.com

Centiel AG: Shareholders Board Members Managers and Company Profile | CH0024666528 - marketscreener.com

USDrugAcqII (DMIIU) Stock Mutual Fund Trade (+0.10%) 2026-04-20Market Hype - Cổng thông tin điện tử tỉnh Lào Cai

AmDrug Acq2 (DMII) Stock: Is It a Compelling Buy (Idled) 2026-04-20Rating Change - Cổng thông tin điện tử tỉnh Lào Cai

Is AmericanDrug (DMAAR) stock exposed to downside risk (Selloff Intensifies) 2026-04-20Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai

US Drug Acq (DMAA) Stock Upgrade Alert (Stuck) 2026-04-18Expert Breakout Alerts - Xã Châu Thành

Drugs Made In America Acquisition Corp.: Valuation Ratios, Analysts' Forecasts - marketscreener.com

Vote math updated for Drugs Made In America (DMAA) in proxy amendment - Stock Titan

Drugs Made In America Acquisition II Corp. 10-K Annual Report: Business Strategy, Acquisition Focus, and Management Overview - Minichart

Drugs Made In America Acquisition Corp. (DMAA): SPAC Focusing on AI, Machine Learning, and Pharmaceutical Acquisition Opportunities - Minichart

Drugs Made In America Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Drugs Made In America (NASDAQ: DMAA) details SPAC cash, LOI and risks - Stock Titan

Drugs Made In America Acquisition II Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Drugs Made In America Acquisition II (DMII) logs $4.2M income, flags going-concern risk - Stock Titan

Paloma Acquisition Corp I: Performance & Quotes, PALO Stock Price on Nasdaq Exchange - marketscreener.com

Drugs Made In America Acquisition 10-K: $0 revenue, $5.94M net income, ($0.28M) net loss - TradingView

Drugs Made in America (DMAA) asks investors to extend SPAC deal deadline - Stock Titan

Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest - MarketBeat

Drugs Made In America Acquisition Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com

MRLN|Inflection Point Acquisition IV Ord Shs Class A|Price:13.660|Chg%:0.08 - TradingKey

Weekly Recap: Is Drugs Made In America Acquisition Corp a momentum stock2026 Stock Rankings & High Conviction Trade Alerts - baoquankhu1.vn

JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat

Aug Chart Watch: What makes Drugs Made In America Acquisition Corp stock attractive today2026 Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn

Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%What's Next? - MarketBeat

Targets Report: Can Drugs Made In America Acquisition Corp Equity Right deliver alphaStop Loss & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn

Drugs Made In America Acquisition Corp.Rights (NQ: DMAAR - The Chronicle-Journal

Drugs Made In America Acquisition Corp. Signs LOI for De-SPAC Merger with Power Analytics Global Corp - Minichart

Power Analytics Global Corp signed a letter of intent to acquire Drugs Made In America Acquisition Corp. in a reverse merger transaction for $1.0 billion. - marketscreener.com

Drugs Made In America Acquisition II Corp. Unit (DMIIU) Competitors - Meyka

Drugs Made in America SPAC Signs Power Analytics LOI - TipRanks

Drugs Made in America Acquisition Corp. signs LOI for de-SPAC with Power Analytics - Investing.com

Drugs Made In America Acquisition CorpEnters Loi For De-Spac With Power Analytics Global CorpSEC Filing - TradingView

Drugs Made in America to pursue de-SPAC with Power Analytics Global at ~$1.0B valuation - TradingView — Track All Markets

De-SPAC LOI values Power Analytics at $1.0B with DMAA (NASDAQ: DMAA) - Stock Titan

Proem Acquisition Corp I: Performance & Quotes, PAAC Stock Price on Nasdaq Exchange - marketscreener.com

Idea Acquisition Corp.: Performance & Quotes, IACO Stock Price on Nasdaq Exchange - marketscreener.com

Willow Lane Acquisition Corp. II: Performance & Quotes, WLII Stock Price on Nasdaq Exchange - marketscreener.com

Why Is Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Stock Up Today? - Meyka

Death Cross: Can Drugs Made In America Acquisition Corp Equity Right sustain earnings growth2026 Sector Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn

Chart Watch: Is Drugs Made In America Acquisition Corp Equity Right stock influenced by commodity pricesEarnings Overview Summary & Risk Controlled Swing Alerts - baoquankhu1.vn

Are executives confident in DMA Acq II (DMIIR) Stock | Price at $0.08, Up 17.25%Institutional Grade Stocks - Cổng thông tin điện tử Tỉnh Sơn La

Is AmDrug Acq2 (DMII) Stock in a Downtrend | Price at $9.98, Down 0.05%Trending Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La

Drugs Made In America Acquisition II Corp. Announces $1.4 Million Convertible Notes Financing Agreement with Alpha Multi Family Office - Minichart

MercadoLibre, Inc. Launches 2026 Long Term Retention Program for Key Employees (8-K Filing) - minichart.com.sg

Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement - Investing.com Australia

Drugs Made In America II Issues Interim Convertible Note - TipRanks

Drugs Made In America Acquisition II Finalizes $1.4M Notes Deal, Adds $300K Interim Convertible - TradingView

$300K zero‑interest note backs Drugs Made In America II (NASDAQ: DMII) - Stock Titan

Drugs Made in America Acquisition II Delays Annual Filing - TipRanks

Drugs Made in America Delays Annual Filing - TipRanks

Late 10-K notice — Drugs Made in America (NASDAQ: DMAA) delays FY2025 filing - Stock Titan

DMII (NASDAQ: DMII) files 12b-25—expects to file 10-K by Apr 15, 2026 - Stock Titan

Drugs Made In America Acquisition II Corp.Right (Nasdaq:DMIIR) Stock Quote - The Chronicle-Journal

CAQ|Cambridge Acquisition Ord Shs Class A|Price:9.850| - TradingKey

Pfizer Inc. - Britannica

BCSS

$10.17

0.10%

EVAC

$10.13

0.00%

CEPF

$10.24

0.15%

UMAC

$14.49

2.23%

CCXI

$10.24

0.00%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く